Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05514782 · ClinicalTrials.gov registry record · NA
A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum
A NA study, sponsored by Revision Skincare.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT05514782 is a NA study that has completed, run by Revision Skincare. The registered enrollment target is 67 participants.
The verdict
NCT05514782, a NA study, has completed, sponsored by Revision Skincare.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
This double-blind, randomized, placebo-controlled, single-center clinical trial was conducted to assess the efficacy and tolerance of an anti-aging daily serum to improve moderate overall photodamage and skin fatigue after 12-weeks of twice-daily used when compared to a placebo-serum (vehicle control). A total of 62 subjects, 34-60 years of age completed study participation.
Interventions
- OTHER Facial Moisturizer
- OTHER Cleansing Lotion
- OTHER Sunscreen SPF 40+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2021-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05514782
The ClinicalTrials.gov registry entry for NCT05514782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Facial Moisturizer is the first listed.
NCT05514782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05514782 about?
NCT05514782 is a clinical study titled "A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum". This double-blind, randomized, placebo-controlled, single-center clinical trial was conducted to assess the efficacy and tolerance of an anti-aging daily serum to improve moderate overall photodamage and skin fatigue after 12-weeks of twice-daily used when compared to a placebo-serum (vehicle contro...
What is the current status of trial NCT05514782?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2021-09-15. Estimated completion is 2021-12-10.
What interventions are being tested in trial NCT05514782?
The interventions under investigation include: Facial Moisturizer (OTHER), Cleansing Lotion (OTHER), Sunscreen SPF 40+ (OTHER).
Who is sponsoring clinical trial NCT05514782?
This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.